Navigation Links
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Date:11/18/2011

tly and time-consuming monthly office visits for patients and their caregivers."

"This approval is an important step forward for Regeneron and for patients suffering with wet AMD, the most common cause of blindness in the U.S. in older adults," said Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron.  "We thank the patients and clinical investigators who participated in our clinical studies, the FDA, and the Regeneron employees who helped make this day possible.  Now that EYLEA is approved, we plan to make EYLEA available to patients within the next few days." 

About EYLEA™ (aflibercept) Injection Vascular Endothelial Growth Factor (VEGF) is a naturally occurring protein in the body.  Its normal role in a healthy organism is to trigger formation of new blood vessels (angiogenesis) supporting the growth of the body's tissues and organs.  However, in certain diseases, such as wet age-related macular degeneration, it is also associated with the growth of abnormal new blood vessels in the eye, which exhibit abnormal increased permeability that leads to edema. Scarring and loss of fine-resolution central vision often results.  

EYLEA, known in the scientific literature as VEGF Trap-Eye, is a recombinant fusion protein, consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 and formulated as an iso-osmotic solution for intravitreal administration.  EYLEA acts as a soluble decoy receptor that binds VEGF-A and placental growth factor (PlGF) and thereby can inhibit the binding and activation of these cognate VEGF receptors.

EYLEA is indicated for the treatment of patients with neovascular age-related macular degeneration (wet AMD).  EYLEA is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipien
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
2. Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
3. Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
4. Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting
5. Regeneron Reports Second Quarter 2011 Financial and Operating Results
6. Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
7. Trading in Regeneron Common Stock Halted
8. Regeneron Reports First Quarter 2011 Financial and Operating Results
9. Regeneron Announces Presentation at the Bank of America Merrill Lynch 2011 Health Care Conference
10. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
11. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... TORONTO , Aug. 27, 2015 /PRNewswire/ ... announced the issuance of a white paper on the ... spray product.  The white paper was presented to the ... by Dr. James H. Anderson, Jr. , MD, ... be viewed online on the Generex website. ...
(Date:8/27/2015)... Aug. 27, 2015  PinnacleHealth CardioVascular Institute enrolled the first ... the United States in a trial ... stent for blockages in the main artery of the leg. ... and potentially less risk for stent fracture or re-narrowing after ... single-arm, multicenter clinical trial of the BioMimics 3D Stent System ...
(Date:8/27/2015)... 27, 2015 According to ... Research titled "Global Market Study on Urinary Catheters: ... 2021", the urinary catheters market is expected to be valued ... It is anticipated to expand at a CAGR ... Mn by 2021. View full report TOC ...
Breaking Medicine Technology:Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4First Pennsylvania Patient Treated in Landmark Vascular Study 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 3Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 4
... Mobile Dog Heart Health Tour is heading south to ... health examinations in San Antonio,s McAllister Dog Park. From ... veterinary cardiologists will be performing on site heart screenings ... owners about canine heart disease. (Photo: ...
... Celsis In Vitro, Inc. (Celsis IVT) announced today ... District of Illinois in Chicago has entered a preliminary ... (the Defendants) due to their infringement of U.S. Patent ... California (Nasdaq: LIFE ) is the parent ...
Cached Medicine Technology:Free Dog Heart Checks at McAllister Park 2Free Dog Heart Checks at McAllister Park 3Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 2Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 3
(Date:8/27/2015)... ... August 27, 2015 , ... For the first time, ... with the Nutri Ninja® Auto-iQ Pro Complete and Nutri Ninja Auto-iQ Compact System. ... takes drink customization to a whole new level. This line of Nutri Ninja ...
(Date:8/27/2015)... ... August 27, 2015 , ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue ... of 2016. The new facility will be located at US Highway 19 North and Highlands ... on August 18, and work on the project is slated to begin in September 2015. ...
(Date:8/27/2015)... ... 27, 2015 , ... King Kullen, America’s First Supermarket, is celebrating 85 years ... in 1930 and recognized by the Smithsonian Institute as America’s First Supermarket, King Kullen ... the Cullen & Kennedy families have created a culture of caring while building their ...
(Date:8/27/2015)... ... August 27, 2015 , ... Since ... has grown to having twelve offices in three counties, LA, Orange and San ... Southern California region. Founded by Dr. Richy Agajanian, the Oncology Institute of ...
(Date:8/27/2015)... ... 27, 2015 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that Ms. Esther Sadler-Williams, Global Director Strategic Development and ... Radisson Blu Edwardian Hotel, London Heathrow, on September 9th – 10th, 2015. , ...
Breaking Medicine News(10 mins):Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 2Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 3Health News:SharkNinja's Nutri Ninja® Auto-iQ™ Pro Complete Delivers Power And Versatility In A Compact Design 4Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:King Kullen Honors Their 85 Years of Success this August 2Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2Health News:Clinical Trial Supply Chain Logistics to be Discussed By Catalent Expert at Upcoming Flypharma Conference 2
... ... Medical Chart Conversions to all ePaperless Solutions’ EMR System Clients on the East Coast ... ... -- Scantronix.net, an industry leader in electronic medical record (EMR) scanning, digitization and ...
... Jan. 15 Equinox Holdings, Inc. (the "Company") announced ... eligible purchasers, subject to market and other conditions, of ... 2016 (the "Notes").  The Notes will be guaranteed on a ... future subsidiaries that guarantee the Company,s new revolving credit facility, ...
... ... ( www.PharmaPack-US.com ), a Division of Label-Aire ( www.label-aire.com ) ... Mexico.,PharmaPack packaging machines are manufactured to cGMP specifications and our ... meet customers’ needs. Our product line consists of Unscramblers, ...
... ... of therapy products designed to relieve back pain and neck pain, is set to launch ... , ... 15, 2010 -- Tranquil Touch , LLC is proud to announce the launch of ...
... , ... have partnered to bring the CyberKnife Stereotactic Radiosurgery System to Miami , ... Chicago, IL (PRWEB) January 15, 2010 -- Accelitech ... in partnership with Mercy Hospital in Miami, Florida. , , ,With the launch of the ...
... Highly ... graduate , ... Nexis) January 15, 2010 -- The McGarity Group, a Gwinnett County law firm with special ... Braham has joined the firm as an associate attorney., , ,Braham began her professional ...
Cached Medicine News:Health News:Scantronix and ePaperlessSolutions Form Key Partnership 2Health News:Scantronix and ePaperlessSolutions Form Key Partnership 3Health News:Equinox Holdings, Inc. Commences $400 Million Private Debt Offering 2Health News:New Provider of Tablet/Capsule Packaging Solutions For Offers State-of-the-Art Equipment In The United States & Mexico 2Health News:Tranquil Touch, LLC to Introduce TheraPostion™ at the 2010 Parker Chiropractic Seminar in Las Vegas 2Health News:Tranquil Touch, LLC to Introduce TheraPostion™ at the 2010 Parker Chiropractic Seminar in Las Vegas 3Health News:Anne Marie Braham Joins The McGarity Group as Associate Attorney 2
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
Great for small incisions and excision needs...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
2.5mm...
Medicine Products: